Loading ... Loading ...
Lingua:      

  NEWS

    
ADAPTING THE ADPKD OUTCOMES MODEL TO PREDICT COST CONSEQUENCE IN ITALIAN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) TREATED WITH JINARC (TOLVAPTAN)
Mennini FS, Marcellusi A, Russo S, Iorio A, Lanati EP, Robinson P
Poster PND 39. Milan, ISPOR 18th European Congress 2015
PROTON PUMP INHIBITORS IN ITALY: IT’S TIME TO MAKE A (POLICY) CHANGE
Lidonnici D, Lanati EP
Poster PGI 54. Milan, ISPOR 18th European Congress 2015
NUTRITIONAL ASPECTS AND DISINFORMATION IN LIVER DISEASE: A QUESTIONNAIRE-BASED SURVEY IN ITALIAN PATIENTS
Gardini I, Lanati EP, Caporaso N, Fontana R, Lidonnici D
Poster PGI 47. Milan, ISPOR 18th European Congress 2015
BUDGET IMPACT ANALYSIS OF TRIPLIAM FOR THE TREATMENT OF HYPERTENSION IN ITALY
Lanati EP, Orlando VL
Poster PCV 61. Milan, ISPOR 18th European Congress 2015
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors.
Sacchini D, Craxì L, Refolo P, Minacori R, Cicchetti A, Gasbarrini A, Cammà C, Spagnolo AG; WEF Study Group
Digestive and Liver Disease. 2015 May;47(5):351-5.
ECONOMIC ASSESSMENT OF ELTROMBOPAG IN THE TREATMENT OF THROMBOCYTOPENIA
Romano F, Ruggeri M, Coretti S, Giannini EG, Sacchini D, Annicchiarico BE, Marchetti M, Rodeghiero F, Lidonnici D
Poster PGI 22. Milan, ISPOR 18th European Congress 2015
ECONOMIC ASSESSMENT OF ELTROMBOPAG IN THE TREATMENT OF THROMBOCYTOPENIA
Romano F, Ruggeri M, Coretti S, Giannini EG, Sacchini D, Annicchiarico BE, Marchetti M, Rodeghiero F, Lidonnici D
Expert Review of Pharmacoeconomics & Outcomes Research, 2015;15(4):713-20.
COHORT OF HCV PATIENTS IN ITALY: SIZING AND TREATMENTS IN A SAMPLE OF ITALIAN HEPATOLOGY CENTERS
Lanati EP, Lidonnici D, Gasbarrini A, Ruggeri M, Sacchini D, Caporaso N, Fagiuoli S
Poster PGI 47. Amsterdam, ISPOR 17th European Congress 2014
PATIENTS DIAGNOSTIC THERAPEUTIC PATHWAYS FOR HCV PATIENTS IN ITALY: IMPACT OF REGIONALIZATION IN TREATMENTS AND GUIDELINES
Lanati EP, Lidonnici D, Gasbarrini A, Ruggeri M, Sacchini D, Caporaso N, Fagiuoli S
Poster PGI 55. Amsterdam, ISPOR 17th European Congress 2014
ECONOMIC EVALUATION OF AGOMELATINE FOR MAJOR DEPRESSIVE DISORDERS RELATIVE TO OTHER ANTIDEPRESSANTS IN THE ITALIAN SETTING
Lanati EP, Lidonnici D
Poster PMH 36. Amsterdam, ISPOR 17th European Congress 2014
EXPERT OPINION OF NEPHROLOGISTS ABOUT THE EFFECTIVENESS OF LOW-PROTEIN DIET IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE (CKD).
Trifirò G, Fatuzzo PM, Ientile V, Pizzimenti V, Ferrajolo C, Santoro D, Camacho N, Van Rosmalen J, D'Addetta G, Lanati EP, Caputi AP, Catinello G, Savica V
International Journal of Food Sciences and Nutrition. September 2014, Volume 29, pp 1-6.
HOW THE PRICING STRATEGY OF 2ND GENERATION HCV DIRECT ANTIVIRAL AGENTS CAN AFFECT THE NUMBER OF TREATED PATIENTS IN ITALY AND THE NATIONAL DRUG BUDGET
Lanati EP,Lidonnici D, Cammà C and the WEF study group
Poster PGI 47. Dublino, ISPOR 16th European Congress 2013
I QUADERNI DI MEDICINA IL SOLE24ORE SANITA’ – LUGLIO 2013
Cicchetti A, Gasbarrini A, Ruggeri, M, Romano F, Cammà C, Marchetti M, Carletto A, Sacchini D, Refolo P, Minacori R, Carosi G, Caraceni P, Taliani G, Fagiuoli S, Lucà MG, Magini G, De Giorgio M, Oleari F, Gardini I, Giannini EG, Raimondo G, Saitta C, Toniutto P, Farinati F, Castelli G, Cabibbo G, Turriziani A, Grieco A, Biolato M, Spagnolo AG
Terzo Workshop di Economia e Farmaci in Epatologia - WEF-IBD 2013
I QUADERNI DI MEDICINA IL SOLE24ORE SANITA’ – GIUGNO 2013
Cicchetti A, Gasbarrini A, D’Incà R, Caporaso N, Musto D, Nardone OM, Armuzzi A, Orlando A, Blandizzi C, Castiglione F, Testa A, Annese V, Danese S, Ruggeri, M, Romano F, Cappello M, Cammà C, Bravatà I, Marchetti M, Carletto A, Sacchini D, Refolo P, Minacori R, Canarecci S, Greco M, Leone S
Primo Workshop di Economia e Farmaci per le Malattie Infiammatorie Croniche Intestinali - WEF-IBD 2013
NEW ANTIVIRAL DRUGS FOR HEPATITIS C IN ITALY: WILL IT BE A TREASURE HUNT?
Gardini I, Fontana R, Fumagalli M, Conforti M, Lanati EP
Poster PGI 32. Berlino, ISPOR 15th European Congress 2012
SCAN: AN INTEGRATED SYSTEM FOR MARKET ACCESS OF NEW DRUGS IN ITALY
Lanati EP, D’ausilio A, Lidonnici D, Iorio A, Jommi C
Poster PRM 24. Madrid, ISPOR 14th European Congress 2011
VALUTAZIONE ECONOMICA DI UN PROGRAMMA DI SCREENING ANTI-HCV IN ITALIA
Cicchetti A, Ruggeri M, Coretti S, Piscaglia A, Ponziani FR, Lanati EP e Gasbarrini A
Pharmacoeconomics – Italian Research Articles. July 2011, Volume 13, Issue 2, pp 81-99
LA DIETA IPOPROTEICA NELLA GESTIONE DEL PAZIENTE NEFROPATICO IN CAMPANIA: UN’ANALISI DI IMPATTO DI BUDGET
D’Ausilio A, Lanati EP, Quintaliani G
Poster 4° Congresso Nazionale SIHTA 2011